Can torsades de pointes occur without a prolonged corrected QT interval?

No, true torsades de pointes (TdP) should not occur without QT prolongation—by definition, TdP requires marked QT prolongation.

The term "torsades de pointes" should be confined exclusively to polymorphic ventricular tachycardias occurring with marked QT-interval prolongation (>500 ms) and QT-U deformity, as these represent a distinct mechanistic and therapeutic entity 1. While the term has been misapplied to describe polymorphic ventricular arrhythmias without QT prolongation, this represents imprecise nomenclature rather than accurate diagnosis.

The Defining Relationship Between QT Prolongation and TdP

The mechanistic foundation of TdP is rooted in prolonged ventricular repolarization:

• QTc >500 ms represents the critical threshold associated with 2- to 3-fold higher risk for TdP in both congenital long QT syndrome and drug-induced cases 1
• Each 10-ms increase in QTc contributes approximately 5-7% exponential increase in TdP risk 1
• The typical initiating sequence (short-long-short R-R pattern) is specifically associated with marked QT prolongation and T-U wave distortion in the last sinus beat before the episode 1

Critical Caveats in Clinical Practice

The Measurement Challenge

QT monitoring alone may be inadequate to predict TdP because:

• Measuring morphologically distorted QT intervals is challenging and prone to interrater differences 1
• T-wave distortion (flattening, bifid T waves, prominent U waves fused with T waves) makes determining the end of the T wave difficult 1
• The QT prolongation may not be evident during normal sinus rhythm but becomes markedly exaggerated after pauses 1

The Exception That Proves the Rule

The case report of azithromycin-induced TdP with "normal" baseline QT (385 ms) 2 illustrates a crucial point: the baseline QT may appear normal, but dynamic QT prolongation occurs with the offending agent or after pauses. This is not TdP without QT prolongation—it's TdP where the QT prolongation was either not captured on the baseline ECG or developed acutely.

Practical Algorithm for Assessment

When evaluating polymorphic ventricular tachycardia:

1. Measure the QTc during sinus rhythm (ideally the beat immediately preceding the arrhythmia)
2. Look specifically at the post-pause beats where QT prolongation is most exaggerated
3. Assess for T-U wave deformity, not just QT duration
4. If QTc <500 ms and no T-U deformity: Consider alternative diagnoses (ischemic polymorphic VT, catecholaminergic polymorphic VT, Brugada syndrome)
5. If QTc >500 ms with characteristic twisting morphology: Diagnose as TdP and manage accordingly

Risk Stratification Without Visible Prolongation

In rare cases where baseline QTc appears borderline (460-500 ms range), multiple risk factors can unmask latent repolarization abnormalities 3, 4:

• Female sex
• Hypokalemia, hypomagnesemia, hypocalcemia
• Bradycardia (<45 bpm) 5, 6
• Drug-drug interactions
• Genetic susceptibility (subclinical congenital LQTS)

These patients may develop critical QT prolongation dynamically, particularly after pauses or with heart rate changes, even if the resting ECG appears acceptable 7.

Bottom Line for Clinical Decision-Making

If you witness polymorphic VT with the characteristic twisting morphology and cannot document QT prolongation, you have three possibilities:

1. You missed the QT prolongation (most likely—check post-pause beats, check different leads)
2. It's not actually TdP (it's a different form of polymorphic VT requiring different management)
3. The patient has concealed/dynamic QT prolongation that wasn't captured on your ECG

Do not diagnose TdP without documented QT prolongation, as this distinction fundamentally changes management (magnesium and pacing for TdP vs. other antiarrhythmics or ablation for alternative polymorphic VTs).